198 related articles for article (PubMed ID: 10465468)
21. Survival benefit of post-mastectomy radiotherapy in breast carcinoma patients with T1-2 tumor and 1-3 axillary lymph node(s) metastasis.
Duraker N; Demir D; Bati B; Yilmaz BD; Bati Y; Çaynak ZC; Sobutay E
Jpn J Clin Oncol; 2012 Jul; 42(7):601-8. PubMed ID: 22511807
[TBL] [Abstract][Full Text] [Related]
22. Prognostic significance of apex axillary invasion for locoregional recurrence and effect of postmastectomy radiotherapy on overall survival in node-positive breast cancer patients.
Kuru B; Camlibel M; Dinc S; Gulcelik MA; Alagol H
World J Surg; 2004 Mar; 28(3):236-41. PubMed ID: 14961194
[TBL] [Abstract][Full Text] [Related]
23. Analysis in early stage triple-negative breast cancer treated with mastectomy without adjuvant radiotherapy: patterns of failure and prognostic factors.
Chen X; Yu X; Chen J; Zhang Z; Tuan J; Shao Z; Guo X; Feng Y
Cancer; 2013 Jul; 119(13):2366-74. PubMed ID: 23576181
[TBL] [Abstract][Full Text] [Related]
24. A positive margin is not always an indication for radiotherapy after mastectomy in early breast cancer.
Truong PT; Olivotto IA; Speers CH; Wai ES; Berthelet E; Kader HA
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):797-804. PubMed ID: 14967436
[TBL] [Abstract][Full Text] [Related]
25. Locoregional failure of postmastectomy patients with 1-3 positive axillary lymph nodes without adjuvant radiotherapy.
Cheng JC; Chen CM; Liu MC; Tsou MH; Yang PS; Jian JJ; Cheng SH; Tsai SY; Leu SY; Huang AT
Int J Radiat Oncol Biol Phys; 2002 Mar; 52(4):980-8. PubMed ID: 11958892
[TBL] [Abstract][Full Text] [Related]
26. Stage and pattern of metastases in patients with breast cancer.
Kamby C; Rose C; Ejlertsen B; Andersen J; Birkler NE; Rytter L; Andersen KW; Zedeler K
Eur J Cancer Clin Oncol; 1987 Dec; 23(12):1925-34. PubMed ID: 3436355
[TBL] [Abstract][Full Text] [Related]
27. Risk factors of locoregional relapse in locally advanced breast cancer treated with neoadjuvant chemotherapy following mastectomy and radiotherapy.
Huang L; Chen S; Yang WT; Shao Z
Oncotarget; 2017 Jun; 8(24):39703-39710. PubMed ID: 28055977
[TBL] [Abstract][Full Text] [Related]
28. Postmastectomy radiotherapy improves disease-free survival of high risk of locoregional recurrence breast cancer patients with T1-2 and 1 to 3 positive nodes.
He ZY; Wu SG; Zhou J; Li FY; Lin Q; Lin HX; Sun JY
PLoS One; 2015; 10(3):e0119105. PubMed ID: 25781605
[TBL] [Abstract][Full Text] [Related]
29. Impact of locoregional treatment on the early-stage breast cancer patients: a retrospective analysis.
van der Hage JA; Putter H; Bonnema J; Bartelink H; Therasse P; van de Velde CJ;
Eur J Cancer; 2003 Oct; 39(15):2192-9. PubMed ID: 14522378
[TBL] [Abstract][Full Text] [Related]
30. Profile of prognostic factors in 1022 Indian women with early-stage breast cancer treated with breast-conserving therapy.
Dinshaw KA; Budrukkar AN; Chinoy RF; Sarin R; Badwe R; Hawaldar R; Shrivastava SK
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1132-41. PubMed ID: 15978744
[TBL] [Abstract][Full Text] [Related]
31. Locoregional failure 15 years after mastectomy in women with one to three positive axillary nodes with or without irradiation the significance of tumor size.
Fodor J; Polgár C; Major T; Németh G
Strahlenther Onkol; 2003 Mar; 179(3):197-202. PubMed ID: 12627264
[TBL] [Abstract][Full Text] [Related]
32. Clinical outcome of isolated locoregional recurrence in patients with breast cancer according to their primary local treatment.
Shenouda MN; Sadek BT; Goldberg SI; Keruakous AR; Croft BJ; Abi Raad RF; Taghian AG
Clin Breast Cancer; 2014 Jun; 14(3):198-204. PubMed ID: 24485702
[TBL] [Abstract][Full Text] [Related]
33. Radiation therapy and survival in breast cancer patients with 10 or more positive axillary lymph nodes treated with mastectomy.
Diab SG; Hilsenbeck SG; de Moor C; Clark GM; Osborne CK; Ravdin PM; Elledge RM
J Clin Oncol; 1998 May; 16(5):1655-60. PubMed ID: 9586875
[TBL] [Abstract][Full Text] [Related]
34. High tumour stage and margin clearance are still important prognostic factors for post-mastectomy locoregional recurrence in Malaysia.
Choong LP; Taib NA; Rampal S; Saad M; Bustam AZ; Yip CH
Asian Pac J Cancer Prev; 2010; 11(5):1409-16. PubMed ID: 21198302
[TBL] [Abstract][Full Text] [Related]
35. Prognostic factors for death after an isolated local recurrence in patients with early-stage breast carcinoma.
Lê MG; Arriagada R; Spielmann M; Guinebretière JM; Rochard F
Cancer; 2002 Jun; 94(11):2813-20. PubMed ID: 12115367
[TBL] [Abstract][Full Text] [Related]
36. Prognostic factors for breast cancer patients with T1-2 tumor and 1-3 positive axillary nodes treated using total mastectomy without radiotherapy.
Asaga S; Kinoshita T; Shiino S; Jimbo K; Takayama S
Breast J; 2019 Jan; 25(1):26-33. PubMed ID: 30414218
[TBL] [Abstract][Full Text] [Related]
37. Locoregional recurrence in patients with one to three positive axillary nodes after mastectomy without adjuvant radiotherapy.
Cheng JC; Chen CM; Liu MC; Tsou MH; Yang PS; Cheng SH
J Formos Med Assoc; 2000 Oct; 99(10):759-65. PubMed ID: 11061070
[TBL] [Abstract][Full Text] [Related]
38. [Breast-conservation treatment for early invasive breast cancer: prognostic factors for survival after salvage treatment of local recurrence].
Fodor J
Magy Onkol; 2007; 51(2):127-31. PubMed ID: 17660868
[TBL] [Abstract][Full Text] [Related]
39. Prognostic value of breast cancer subtypes on breast cancer specific survival, distant metastases and local relapse rates in conservatively managed early stage breast cancer: a retrospective clinical study.
Sanpaolo P; Barbieri V; Genovesi D
Eur J Surg Oncol; 2011 Oct; 37(10):876-82. PubMed ID: 21824742
[TBL] [Abstract][Full Text] [Related]
40. [Prognostic value of estrogen receptor, progesterone receptor and human epidermal growth factor receptor-2 in node positive breast cancer patients treated by mastectomy].
Wang SL; Li YX; Song YW; Wang WH; Jin J; Liu YP; Liu XF; Yu ZH
Zhonghua Zhong Liu Za Zhi; 2010 Jul; 32(7):520-5. PubMed ID: 21029696
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
